Trial intelligence / Profile preview

Comparison of violet plant vaginal gel vs metronidazole tablets for Trichomonas vaginalis

IRCT20240529061938N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Jul 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of metronidazole in trichomoniasis (trich) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Clinical and microbiological cure of Trichomonas vaginalis infection. Started Jul 2024; status: completed.

02

Drugs

metronidazole
03

Conditions

trichomoniasis (trich)

Beyond the preview

Go deeper on IRCT20240529061938N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20240529061938N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call